3542 results for «2144»
3542 results
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
What is new in radial access in 2025
20 May 2025 – From EuroPCR 2025
Explore the latest developments in radial access for PCI as of 2025. Topics include distal versus conventional transradial access, techniques to reduce forearm complications, sheathless approaches, dual artery compression methods, and feasibility in high bleeding risk patients.
Pushing boundaries in complex PCIs: unique DES technology for complex lesions and patients
21 May 2025 – From EuroPCR 2025
Explore cutting-edge strategies in complex PCI through four detailed clinical cases: a challenging left main bifurcation, a complex procedure using Guideliner Extension Catheters (GEC), an acute coronary syndrome intervention, and treatment of a patient with high bleeding and ischemic risks. This session demonstrates how thorough patient...
Challenging scenarios in acute coronary syndrome
20 May 2025 – From EuroPCR 2025
This session presents challenging acute coronary syndrome (ACS) cases with unusual presentations and complications. Learn from cases involving myocarditis mimics, coronary aneurysms, rescue fibrinolysis during PCI, and STEMI complicated by cardiogenic shock, highlighting diagnostic and therapeutic nuances.
Redefining complex PCI: impact of real-world data and novel evidence on IV antithrombotic strategies
21 May 2025 – From EuroPCR 2025
Explore how real-world data and evolving evidence are reshaping IV antithrombotic strategies in complex PCI. This EuroPCR 2025 session brings together urgent clinical cases—including STEMI patients in shock—and highlights key insights from the SMILE registry. Learn how transition protocols from cangrelor to oral P2Y12 inhibitors are...
DCB in de novo lesions: new valid option?
20 May 2025 – From EuroPCR 2025
Explore the emerging role of drug-coated balloons (DCB) in treating de novo coronary lesions. This session discusses complexity management, comparisons with drug-eluting stents (DES), and the potential of DCBs as valuable alternatives, especially in high bleeding risk patients.
RevoEdge high pressure cutting balloon in PCI: innovate, cut, and conquer
20 May 2025 – From EuroPCR 2025
Discover how the next-generation RevoEdge high-pressure cutting balloon is transforming PCI with innovative design and proven clinical outcomes. This session presents a multicenter randomised trial and real-world case discussions, showcasing RevoEdge’s effectiveness in tackling resistant, complex lesions—including long, tortuous, and fibrotic cases. Learn practical tips, tricks,...
Best companion's case on complications for stable coronary artery disease PCI: episode 1
20 May 2025 – From EuroPCR 2025
This session focuses on managing complications during PCI for stable coronary artery disease through real-world case presentations. Topics include severe dissections, unexpected procedural complications, and escalation of routine interventions, providing practical insights for complication navigation.
Road to relief - Effective treatment of refractory angina patients with Shockwave Reducer
22 May 2025 – From EuroPCR 2025
Refractory angina affects more than 100 million people globally and is associated with a significantly increased risk of adverse cardiovascular events. Treating this condition effectively remains a major clinical challenge. This session provides detailed insights into the use of the Shockwave Reducer device as an innovative therapeutic...
TAVI - Procedural complications
20 May 2025 – From EuroPCR 2025
Review procedural complications encountered during TAVI, including rare adverse events, management of balloon rupture, annulus rupture with tamponade, and unexpected intraoperative challenges. Gain insights into innovative rescue techniques and decision-making under critical conditions.
Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind”...
Primary PCI outside of the box: unusual STEMI cases
20 May 2025 – From EuroPCR 2025
This session presents unusual STEMI cases managed with primary PCI outside conventional protocols. Cases include heavily calcified lesions, STEMIs with non-flow-limiting stenoses, simultaneous occlusions with cardiac arrest, and other complex presentations, highlighting diverse interventional strategies.
Simplify PCI! Know where and how to win with drug-coated balloon
22 May 2025 – From EuroPCR 2025
This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...
Sirolimus coated balloon for coronary artery disease and peripheral artery disease treatment: the new frontier
20 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session delivers a comprehensive update on the MagicTouch sirolimus-coated balloon (SCB) and its expanding role in treating both coronary and peripheral artery disease (CAD/PAD). The session covers the extensive clinical trial program supporting MagicTouch as a versatile treatment option across multiple indications. It...
Successful finale - Latest best practices and technologies for large hole arterial and venous closure
22 May 2025 – From EuroPCR 2025
This session covers the latest best practices and technologies for large hole arterial and venous closure, focusing on minimising vascular complications.
Learn about a novel patch-based closure system with encouraging early results in TAVI cases, highlighting the importance of deployment angle and ultrasound guidance.
The venous case presentation...
Supraflex for high-risk patients and lesions: from practice to evidence-based medicine proven through FIRE and COMPARE
20 May 2025 – From EuroPCR 2025
Discover the latest evidence on the Supraflex thin-strut sirolimus DES in complex cases—from small vessels and diabetes to STEMI—supported by OCT analysis. This session highlights Supraflex’s performance in high bleeding risk and elderly patients, featuring data from FIRE, COMPARE, EARTH HBR, and Cruz Senior studies. Get...
Symplicity Spyral renal denervation: more insights from clinical practice
21 May 2025 – From EuroPCR 2025
Renal denervation is gaining momentum in the management of hypertension. This EuroPCR 2025 session brings together long-term clinical experience and practical guidance on using the Symplicity Spyral™ system. Learn how to apply the latest European guidelines in daily practice, pick up valuable procedural tips from over...
The future is now: QFR and RMS to optimise coronary artery disease patient management
20 May 2025 – From EuroPCR 2025
See how next-generation technologies are reshaping coronary artery disease treatment in this EuroPCR 2025 session. Learn how QFR is being used to plan PCI and evaluate results, and discover new insights into RMS technology—offering a potential leap beyond traditional drug-eluting stents. From practical case experience to...
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
The Landmark RCT - One-year results
21 May 2025 – From EuroPCR 2025
This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...
